← Back to Patent Explorer
US4447636A Expired / Lapsed US ⏱️ 0.0 years remaining

Synthesis of 11-deoxyprostaglandins

Assignee: Dow Chemical Co
•
Filing: 1982-05-10
•
Granted: 1984-05-08
•
Expires: 2002-05-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Improved procedures and intermediates for synthesizing 11-deoxyprostaglandins wherein trans-2,3-dicarbomethoxycyclopentanone is subjected to a novel alcoholysis with β,β,β-trichloroethanol to substitute a β,β,β-trichlorocarboethoxy group at the 2-position followed by alkylation to allow for a wide range of upper side chains to be introduced at the 2-position of the cyclopentanone ring. The unwanted β,β,β-trichlorocarboethoxy group at the 2-position can then be removed easily by a zinc induced elimination-decarboxylation sequence. Base catalyzed epimerization of the 2-position side chain to the desired trans-configuration, relative to the carbomethoxy group in the 3-position, is followed by partial reduction of the 2-hexynyl moiety of the side chain to the desired cis-olefinic group of the E 2 -type 11-deoxyprostaglandins, or through total reduction to the alkane upper side chain of E 1 -type prostaglandin analogs. Modification thereafter of the carbonyl group at the 3-position of the cyclopentanone ring by a variety of reagents allows introduction of the lower side chain present in the prostaglandins themselves or a variety of other side chains derived from the 3-carboxy-, 3-hydroxymethyl- or 3-aldehyde-substituted cyclopentanone ring. From the latter, 11-deoxyprostaglandins can be prepared by known procedures.

Inventors

  • 👤 William L. White
  • 👤 Peter B. Anzeveno

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 05:32
CPC Classifications
C; C07; C07C; C07C255/00; C07C255/45

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 1 words
Trans-2-β,.beta.,β-trichlorocarboethoxy-3-carbomethoxycyclopentanone.
Claim 2
Dependent Claim 1 words
Trans-2-β,.beta.,β-trichlorocarboethoxy-3-carbomethoxycyclopentanone.

References Cited (Backward Citations)

US3828026A Cited
US4125556A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-05-08 1987-11-07 1988-05-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-05-08 1991-11-07 1992-05-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-05-08 1995-11-07 1996-05-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag